Our group has an important transversal component, and research linesfocused in the development of test for new drugs, biomarkers, or molecules ofinterest for the research.
Our main areas of interest are:
1) Massive data analysis. We are investigating how use the millions of biological results generated in our clinical laboratories to extract new information and improve the diagnosis ofdiseases, defining reference intervals tailored toeach individual, and aiming towards a personalized medicine.
2) Development of analytical methods for new drugs and biomarkers. We use targeted mass spectrometry to detect and measure proteinsand molecules of interest, and genetic tools for DNA and RNA markers. We workin close collaboration with pathophysiology oriented research groups (rarediseases, oncology, infectious diseases, neurology, and nephrology) to developthe measure of clinically useful biomarkers and drugs or tounderstand the etiology of diseases of unknown cause.
